Madrid Stock Exchange:ORY.MC

<!-- Name:DistributionId Value:8751894 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

Eurostars-3 collaborative project with Danish institutions ImProTher and University of Copenhagen Global budget of 1.4 million euros; Oryzon to receive up to 400,000 euros Project will assess the efficacy of iadademstat in combination…

Robust, rapid and durable efficacy - ORR 81%, of which 64% are CR/CRi68% of CR/CRi lasting more than 6 monthsLongest remission + 3 yearsIadademstat and azacitidine combination shows a good safety profileDosing of iadademstat established…

Kabuki Syndrome Foundation Annual Conference11th Drug Discovery Strategic SummitInv€$tival Showcase LSX Leaders 2022Jefferies London Healthcare Conference 2022 MADRID, Spain and BOSTON, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Oryzon…